Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.Lilly...
Centessa Pharmaceuticals PLC
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025.Antranik Tavitian |...
Stocks making the biggest moves premarket: McCormick, Diageo, Nvidia & more
Check out the companies making the biggest moves premarket: McCormick — Shares rose more than 3% after Unilever confirmed it...
